These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2831336)

  • 1. [Semisynthetic beta-lactam antibiotics. V. Metabolism in vitro of 6-[(R)-2-[3-(3,4-dihydroxybenzoyl)-3-(3-hydroxypropyl)-1- ureido]-2-phenylacetamido]penicillanic acid (AO-1100) and surveys on the metabolites].
    Ohi N; Ohsawa Y; Nehashi T; Aoki B; Okazaki A
    Yakugaku Zasshi; 1987 Oct; 107(10):814-8. PubMed ID: 2831336
    [No Abstract]   [Full Text] [Related]  

  • 2. Semisynthetic beta-lactam antibiotics. III. Effect on antibacterial activity and comt-susceptibility of chlorine-introduction into the catechol nucleus of 6-[(R)-2-[3-(3,4-dihydroxybenzoyl)-3-(3-hydroxypropyl)-1-ureido]-2- phenylacetamido]penicillanic acid.
    Ohi N; Aoki B; Kuroki T; Matsumoto M; Kojima K; Nehashi T
    J Antibiot (Tokyo); 1987 Jan; 40(1):22-8. PubMed ID: 3549656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semisynthetic beta-lactam antibiotics. II. Effect on antibacterial activity of ureido N-substituents in the 6-[(R)-2-[3-(3,4-dihydroxybenzoyl)-1- ureido]-2-phenylacetamido]penicillanic acids.
    Ohi N; Aoki B; Moro K; Kuroki T; Sugimura N; Noto T; Nehashi T; Matsumoto M; Okazaki H; Matsunaga I
    J Antibiot (Tokyo); 1986 Feb; 39(2):242-50. PubMed ID: 3957789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semisynthetic beta-lactam antibiotics. I. Synthesis and antibacterial activity of new ureidopenicillin derivatives having catechol moieties.
    Ohi N; Aoki B; Shinozaki T; Moro K; Noto T; Nehashi T; Okazaki H; Matsunaga I
    J Antibiot (Tokyo); 1986 Feb; 39(2):230-41. PubMed ID: 3082839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on beta-lactam antibiotics for medicinal purpose. VII. Synthesis of 6-[D-alpha-(5 and 6-alkyl-4-ethyl-2,3-dioxo-1-piperazinecarboxamido)phenylacetamido]-penicillanic acids and structure-antibacterial activity (author's transl)].
    Takano S; Ochiai H; Nitta J; Komatsu M; Taki H; Tai M; Yasuda T; Saikawa I
    Yakugaku Zasshi; 1979 Apr; 99(4):371-9. PubMed ID: 225465
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on ampicillin and amoxicillin derivatives. III. Synthesis of 6-[2-[(pyrido[2,3-d]pyrimidin-6-yl)methylamino]-2- phenylacetamido]-penicillanic acid derivatives, 6-[2-(4-pyrimidinylamino)-2-phenylacetamido]penicillanic acid derivatives and -cephalosporanic acid derivatives].
    Mishio S; Hirose T; Nakano J; Matsumoto J
    Yakugaku Zasshi; 1987 Aug; 107(8):607-15. PubMed ID: 2828601
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on beta-lactam antibiotics for medicinal purpose. III. Structure-activity relationship of 6-[D(-)-alpha-(4-alkyl-2,3-dioxo-1-piperazinecarbox-amido)phenylacetamido]penicillanic acids (author's transl)].
    Saikawa I; Yasuda T; Taki H; Tai M; Watanabe Y
    Yakugaku Zasshi; 1977 Sep; 97(9):987-94. PubMed ID: 200728
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on beta-lactam antibiotics. V. Synthesis of 6-[D(-)-alpha-(acylamino)-4-hydroxyphenylacetamido]penicillanic acids and antibacterial activity (author's transl)].
    Tobiki H; Yamada H; Tanno N; Shimago K; Eda Y; Noguchi H; Komatsu T; Nakagome T
    Yakugaku Zasshi; 1980 Feb; 100(2):133-9. PubMed ID: 6245204
    [No Abstract]   [Full Text] [Related]  

  • 9. Variation in the potentiation of beta-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria.
    Aldridge KE; Sanders CV; Marier RL
    J Antimicrob Chemother; 1986 Apr; 17(4):463-9. PubMed ID: 3011724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced activity of beta-lactam antibiotics with amdinocillin in vitro and and in vivo.
    Cleeland R; Squires E
    Am J Med; 1983 Aug; 75(2A):21-9. PubMed ID: 6311002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Semisynthetic penicillins. 13. Comparative studies of antibacterial action in vitro of 6-(N,N-1',6'-hexylenformamidino)-penicillanic acid and(D- (D-(minus) alpha-aminobenzyl)-penicillanic acid against clinical pathogenic gram negative strains].
    Jastalska D; Dzierzyńska I; Buśko-Oszczapowicz I; Cieślak J
    Acta Pol Pharm; 1974; 31(3):393-400. PubMed ID: 4368251
    [No Abstract]   [Full Text] [Related]  

  • 12. [Combined effect of 6/N,N-1',6'-hexyleneformamidine-penicillanic acid (preparation HX) and selected beta-lactam antibiotics on E. coli and Salmonella. I. Studies in vitro].
    Zaremba M; Zukowska-Nytko K; Borowski J
    Med Dosw Mikrobiol; 1982; 34(1-2):27-36. PubMed ID: 6292594
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of BL-P1654: a semisynthetic penicillin as a topical ocular therapy.
    Cagle GD; Schlech BA
    Cornea; 1984; 3(1):27-32. PubMed ID: 6100241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro evaluation of ampicillin/brobactam and comparison with other beta-lactam antibiotics.
    Melchior NH; Keiding J
    J Antimicrob Chemother; 1991 Jan; 27(1):29-40. PubMed ID: 1646779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro-In Vivo Discordance with Humanized Piperacillin-Tazobactam Exposures against Piperacillin-Tazobactam-Resistant/Pan-β-Lactam-Susceptible Escherichia coli.
    Monogue ML; Nicolau DP
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7527-7529. PubMed ID: 27799205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination beta-lactam and beta-lactamase-inhibitor therapy: pharmacokinetic and pharmacodynamic considerations.
    Dudley MN
    Am J Health Syst Pharm; 1995 Mar; 52(6 Suppl 2):S23-8. PubMed ID: 7606586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Beta-lactam antibiotics and the immune system of the body].
    Toshkov A; Slavcheva E; Shirova L; Georgiev D; Neĭchev Kh
    Acta Microbiol Bulg; 1981; 9():62-73. PubMed ID: 6285678
    [No Abstract]   [Full Text] [Related]  

  • 18. Morphologic changes produced by amdinocillin alone and in combination with beta-lactam antibiotics: in vitro and in vivo.
    Kramer MJ; Mauriz YR; Timmes MD; Robertson TL; Cleeland R
    Am J Med; 1983 Aug; 75(2A):30-41. PubMed ID: 6311003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro synergistic activity of piperacillin-tazobactam combination against beta-lactam antibiotics resistant strains of Enterobacteriaceae].
    Duex JM; Cordin X; Péchinot A; Siebor E; Kazmierczak A
    Pathol Biol (Paris); 1991 May; 39(5):374-8. PubMed ID: 1652728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-lactam/beta-lactamase inhibitor combinations: pharmacodynamic considerations and possible role in the management of bacterial infections in the neutropenic host.
    Okereke C; Dudley MN
    J Antimicrob Chemother; 1998 Jun; 41 Suppl D():43-9. PubMed ID: 9688450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.